A federal choose has thrown out a settlement that may have shielded the Sackler family, which owned OxyContin maker Purdue Pharma, from future lawsuits over opioids, upending the corporate’s plan to reorganize in chapter courtroom.
U.S. District Choose Colleen McMahon in Manhattan mentioned in a written ruling on Thursday that the chapter courtroom didn’t have the authorized authority to launch the household from legal responsibility.
Purdue and lawyers for the Sacklers couldn’t instantly be reached for remark Thursday night.
The corporate has been accused of pushing huge quantities of its OxyContin ache drug on sufferers, whereas underplaying its potential for habit and abuse, which it has denied. It filed for bankruptcy in 2019, going through a slew of authorized claims over the drug.
U.S. Chapter Choose Robert Drain in September authorized a reorganization plan, together with a settlement of the lawsuits towards the corporate during which the Sacklers would pay $4.5 billion and be launched from future legal responsibility.
McMahon, nonetheless, mentioned chapter regulation didn’t enable such a launch, because the Sacklers had not filed for chapter.